Impact of Renal Dysfunction on Periprocedural Outcomes in Patients with Ischemic Cardiomyopathy Undergoing Elective Percutaneous Coronary Intervention (PCI)
Ischemic cardiomyopathy is associated with multiple comorbidities including diabetes, hypertension, hyperlipidemia, and kidney disease. Patients with end-stage renal disease (ESRD) and left ventricular systolic heart failure have a 2-year cumulative survival as low as 33%. Chronic kidney disease (CKD) increases the risk of contrast-induced nephropathy and progression to ESRD in patients undergoing PCI.
Source: Journal of Cardiac Failure - Category: Cardiology Authors: Aasim Afzal, Tariq Nisar, Aayla Jamil, Aaron Kluger, Joost Felius, Shelley Hall, Parag Kale Tags: 348 Source Type: research
More News: Angioplasty | Cardiology | Cardiomyopathy | Chronic Kidney Disease | Coronary Angioplasty | Diabetes | Endocrinology | Heart | Heart Failure | Hypertension | Kale | Percutaneous Coronary Intervention | Urology & Nephrology